Tg(MS4A1-cre/ERT2)1Mjsk
Transgene Detail
|
Symbol: |
Tg(MS4A1-cre/ERT2)1Mjsk |
Name: |
transgene insertion 1, Mark J Shlomchik |
MGI ID: |
MGI:5545930 |
Synonyms: |
hCD20-TamCre, hCD20TamCre |
Transgene: |
Tg(MS4A1-cre/ERT2)1Mjsk Location: unknown
|
Alliance: |
Tg(MS4A1-cre/ERT2)1Mjsk page
|
|
Strain of Origin: |
Not Specified
|
|
Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Tg(MS4A1-cre/ERT2)1Mjsk expression driven by
1 gene
Transgene expression driven by:
Organism |
Driver Gene |
Homolog in Mouse |
Note |
human |
MS4A1 (931) |
|
|
|
|
|
Mutation details: A BAC (RP11-729B4) containing the human MS4A1 (hCD20) locus was modified by insertion of an IRES-cre/ERT2 (cre recombinase-mutated human estrogen receptor ligand-binding domain fusion) cassette into the 3' untranslated region of the gene. The modified BAC vector was used to generate a transgene that expresses a tamoxifen-inducible cre specifically in B cells. MS4A1 is also expressed from this allele. Line numbers are not available.
(J:184524)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
MS4A1
(human)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:184524 Khalil AM, et al., B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity. Science. 2012 Jun 1;336(6085):1178-81 |
All: |
20 reference(s) |
|